You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

ASCLERA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Asclera, and what generic alternatives are available?

Asclera is a drug marketed by Chemisch Fbrk Krsslr and is included in one NDA.

The generic ingredient in ASCLERA is polidocanol. Two suppliers are listed for this compound. Additional details are available on the polidocanol profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ASCLERA?
  • What are the global sales for ASCLERA?
  • What is Average Wholesale Price for ASCLERA?
Summary for ASCLERA
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 74
Clinical Trials: 3
Patent Applications: 2,638
What excipients (inactive ingredients) are in ASCLERA?ASCLERA excipients list
DailyMed Link:ASCLERA at DailyMed
Drug patent expirations by year for ASCLERA
Recent Clinical Trials for ASCLERA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Massachusetts General HospitalPhase 1
Johns Hopkins UniversityPhase 1
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all ASCLERA clinical trials

Pharmacology for ASCLERA
Drug ClassSclerosing Agent
Mechanism of ActionSclerosing Activity
Physiological EffectVascular Sclerosing Activity

US Patents and Regulatory Information for ASCLERA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chemisch Fbrk Krsslr ASCLERA polidocanol SOLUTION;INTRAVENOUS 021201-001 Mar 30, 2010 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chemisch Fbrk Krsslr ASCLERA polidocanol SOLUTION;INTRAVENOUS 021201-002 Mar 30, 2010 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.